Jim Cramer on Merck (MRK): Stay The Course… It’s Been a Real Tough One

We recently published a list of Jim Cramer Recently Talked About These 9 Stocks. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE: MRK) stands against other stocks that Jim Cramer discussed recently.

On Wednesday, Jim Cramer, the host of Mad Money, shared his thoughts on the market turmoil of the week and provided some valuable lessons. He emphasized that no one ever made a profit by panicking. Cramer pointed out how many investors had thrown in the towel during the downturn.

“Yeah, what happens is they get out and then it rallies big like today, and that’s the end. Bye bye. Learn to take the pain. Staying the course is how you make the biggest money.”

READ ALSO: 10 Stocks on Jim Cramer’s Radar Recently and Jim Cramer Talked About These 8 Stocks.

Cramer noted how, on Tuesday night, anyone holding stocks felt disheartened and as if they had lost substantial sums. He then pointed out that in contrast, those who were shorting the market, including many hedge funds, went to bed feeling victorious. However, Cramer had a different perspective and highlighted that some of the short-sellers, who had bet against the market just before the high opening on Wednesday, might have felt smart in the moment.

But he quickly reminded viewers that while bulls and bears can make money, he commented that “hogs, those who staged short were pigs, plain and simple. He then went on to say:

“The president likes, no, no, he loves drama. He’s gonna love drama for his whole darn presidency. That’s one constant from his first term.”

Cramer said that investors should not expect any certainty from the White House. Hoping for “certainty” from President Trump, he said, would be “kind of nuts” at this point. His advice to investors was simple: when the noise gets overwhelming, “just turn it off”.

“So let me give you the bottom line on this one of the most exciting days of our lives: I don’t think that things are all that difficult. They’re not COVID difficult. Now I think that you’re dealing with manmade crises. It turns out that one of these manmade crises was easily reversible, as we’ve said over and over again, and told you that when you see stocks in the blast zone rally, it pays to realize that good things, not just bad things can happen too.”

Our Methodology

For this article, we compiled a list of 9 stocks that were discussed by Jim Cramer during the episode of Mad Money aired on April 9. We listed the stocks in ascending order of their hedge fund sentiment as of the fourth quarter of 2024, which was taken from Insider Monkey’s database of over 1,000 hedge funds.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).

Jim Cramer on Merck (MRK): Stay The Course... It’s Been a Real Tough One

Merck & Co., Inc. (NYSE:MRK)

Number of Hedge Fund Holders: 91

A caller mentioned that they feel in limbo with Merck & Co., Inc. (NYSE:MRK) and do not know whether to sell or hold onto it. In response, Cramer said:

“You know, first of all, you’re not alone. St. Merck, as we used to call it, has turned into just a complete nightmare. I think that if you buy Merck at a 4% yield though, you’re gonna do well. It did touch $76 today. It’s back to $81. I feel for what you’re doing… It is remarkable how poorly this stock acts. I do want you to stay the course with it right at this point. And I’m sorry because it is been a real tough one.”

Merck (NYSE:MRK) produces a variety of medicines across several health areas. Its work includes cancer treatments, vaccines, and products for animal health. On March 10, Cramer was bullish on the stock as he said:

“Okay, Merck is too cheap. I mean, it’s got a 3.4% yield. Rob Davis is doing very well. It’s really, he’s made a couple acquisitions. I think they’re gonna work out and everyone’s just so scared of the Keytruda patent (the drug has patent protection into 2028) … and that’s not anywhere near. I think you buy the stock of Merck.”

Overall, MRK ranks 2nd on our list of stocks that Jim Cramer discussed recently. While we acknowledge the potential of MRK as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than MRK but that trades at less than 5 times its earnings, check out our report about this cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. This article is originally published at Insider Monkey.